Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis

Figure 3

Inhibition of human vascular endothelial growth factor- (VEGF-) induced corneal neovascularization in rabbit. Mean vessel length ± standard error of the mean (SEM) of new vessels in control and treatment groups (BV: bevacizumab; FcE: Fc-endostatin).